QTTB Q3 2022 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$802,000-52.2% YoY

Gross Profit

$167,00020.8% margin

Operating Income

-$33M-4097.5% margin

Net Income

-$34M-4205.2% margin

EPS (Diluted)

$-10.57

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$263M

Total Liabilities

$54M

Stockholders' Equity

$209M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$802,000	$2M	-52.2%
Gross Profit	$167,000	$2M	-90.0%
Operating Income	-$33M	-$31M	-7.2%
Net Income	-$34M	-$31M	-10.2%